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Abstract 
Natural electromagnetic field background radiation in Earth is 20-30 µT, which is a condition 
in terrestrial evolution. Today, however, in the technosphere-determined environment, 
intermittent extreme low-frequency electromagnetic fields are predominant. In the present 
work, we aim to investigate this topic area by in vivo systematic study of subtoxic and chronic 
electromagnetic field exposures in a turkey model. 
 
Introduction 
Spontaneous electromagnetic radiation (20–30 μT) showed no significant change in the pre-
social time interval of biological evolution provided by terrestrial conditions. Significant 
changes in natural electromagnetic background radiation in terrestrial habitat were begun in the 
20th century with the extensive use of electrical devices. All this resulted in locally increased 
electromagnetic fields (EMF). A few publications on the study of the biological effects of EMF 
(radio frequency, microwaves) examine the question of how low frequency (0 and 300 Hz) 
electromagnetic radiation can affect living organisms, consequently humans [1, 2, 3, 4]. 
Evidence suggests that cell processes can be influences by EMF, it appears that EMF represent 
global stress. Changes in animal behaviour occur in response to a variety of electric field types 
[3]. The effects of noise and extreme low frequency (ELF) EMF are well documented on 
psychological mood and mental disorders. Many animal and human studies have reported 
various effects on the central nervous system and cognitive disorders from exposure to 
electromagnetic fields emitted by mobile phones [5, 6, 7, 8]. 
 
Aims 
In the present work, we intend to investigate this topic area with in vivo model studies of 
subtoxic and chronic ELF EMF exposures. We place particular emphasis on a more in-depth 
study of subtoxic effects, with the aim of possibly proving a hypothesis that environmental 




Adult (♀, certified) turkeys- Meleagris gallopavo (b.w.: 5000–5200 g) were included in our 
studies according to animal care and research protocols (5 animals per group). The turkeys were 
kept together in the experimental protocol, except for treatment time intervals. Prior to the start 
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Extremely low frequency (ELF) electromagnetic field (EMF) exposures 
The exposure was provided by a device capable of producing an intermittent ELF EMF (8 ms 
energy exposure - 2 ms energy-free pause). During the treatment, the cages were covered with 
a 200 cm × 80 cm “magnetic blanket”. In operating mode, the parameters of the Hungarian 
electrical service system (U = 220 V, ν = 50 Hz) were provided. Turkeys were treated with ELF 
EMF exposure at ν = 50 Hz every 8 hours for 20 minutes for 3 weeks after a one-week 
conditioning period. The treatment protocol was followed by a 5-week regeneration phase, i.e., 
a treatment-free time zone. The technical safety of the treatments was controlled by the 
electromagnetic equipment: ME3951A low frequency (NF) analyser, Gigahertz Solutions, 
Germany, B = 10 μT checked: PCE-EMF823 electromagnetic field was performed with a radio 
tester (Tursdale Technicale Services Ltd, UK). 
 
In vivo experimental model 
The experimental protocol was 9 weeks in which we worked with 5 animals per group. In this 
time band, the first week after the conditioning period, ELF EMF (U = 230V, ν = 50Hz, B = 10 
μT) treatment was performed for 3 weeks (in the treatment group), followed by an additional 
five weeks in the time band without treatment the evolution of data patterns of regeneration 
enzymes. Control groups designed for treatments: (AC) absolute control that was not treated; 
(C +) positive control for which the equipment was set in standby mode; (C-) negative control 
for which the machine was turned off mode; and (SC) stress control, in which the entire 
experimental protocol was performed but using an ELF EMF-free blanket. During the 
experiments, blood samples were taken every seven days (in sterile samples of heparin and 
citrate from the subclavian vein), toxicity enzyme parameters were determined. 
 
Enzyme measurement 
Toxicity parameters of the model animals participating in the experimental protocol were 
detected by Dialab methods (DIALAB, Austria). For toxicological monitoring, serum 
biochemical enzyme parameters of blood samples obtained from the subclavian vein: serum 
aspartate aminotransaminase (AST, EC 2.6.1.1) according to Remaley and Wilding, 1989 [9], 
serum alanine aminotransferase (ALT, EC 2.6.1.2) according to Matsuzawa et al., 1997 [10], 
and gamma-glutamyl transpeptidase (γGT: EC 2.3.2.2.) Were measured (3 technical replicates 
and at least 5 replicates). Data were evaluated with ANOVA. 
 
Results 
In our work, our results were related to the absolute control (AC) values, because there was no 
significant difference within the control system (AC, + C; -C; SC), only discrete modulation, 
so the results were presented in the average kinetic relations of the AC controls. 
 




Figure 1. Changes in AST values as a result of ELF EMF treatments and changes in the AST 
enzyme during the regeneration phase (n=3, S: samples, AC: absolute controls, *: p<0.05 
/related to ACs/) 
 
It can be seen that the levels of individual AST enzymes were significantly shifted by ELF EMF 
treatments (2-4 weeks) after the conditioning period (1 week). However, the differences shown 
did not exceed the limits of normal enzyme levels (normal range: 1-40 U/L). AST enzyme 




Figure 2. Changes in ALT values as a result of ELF EMF treatments and changes in the level 
of this enzyme during the regeneration phase (n=3, S: samples, AC: absolute controls, *: 
p<0.05 /related to ACs/) 
 
It can be seen that the individual ALT kinetics were significantly modified by ELF EMF, 
although they remained within normal physiological range (1-50 U/L). Serum ALT enzyme 
levels returned to baseline during the treatment-free, regenerative experimental period. 
 




Figure 3. Changes in γGT enzyme levels as a result of ELF EMF treatments and changes in 
this enzyme level during the regeneration phase (n=3, S: samples, AC: absolute controls, *: 
p<0.05 /related to ACs/) 
 
The figure shows that in vivo ELF EMF exposure significantly altered γGT enzyme levels, 
which returned to baseline levels during the untreated regenerative experimental period. The 
detected enzyme level changes varied within the physiological normal γGT (1-30U/L), enzyme 
level limits. 
 
Discussion and conclusion 
In our previous studies, we have described that the ELF EMF space altered noradrenaline-
activated -adreneregic receptor functions in the time dimension and dose we used. Because 
the aim was to study subtoxic doses, we could also describe that liver enzymes indicating 
toxicity did not leave the normal physiological range. In the present work, however, we 
specifically investigated whether it is possible to find ELF EMF effects following the individual 
liver enzyme kinetics within the range of physiological enzyme levels considered to be very 
broad-spectrum normal.  
The presented kinetic curves clearly demonstrate that in vivo ELF EMF treatments had a direct 
effect on the synthesis results of enzymes signaling the functional function of the liver, 
pancreas, bile, and kidneys. As the ALT / AST ratio was below 1 in all cases, hepatotoxicity 
could be ruled out, so we performed our studies with truly subtoxic doses. 
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